A meta-analysis study [ 1 ] demonstrated use of RGZ was associated with a " significant increase in the risk of myocardial infarction and with an increase in the risk from cardiovascular causes that had borderline significance ".
← all excerpts
Are the adverse effects of glitazones linked to induced testosterone deficiency?
1
—
—